ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
647
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Adma Biologics Inc market cap is $3.02B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adma Biologics Inc 52 week high is $20.46 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adma Biologics Inc 52 week low is $7.21 as of November 18, 2026.
Adma Biologics Inc stock price today is $13.56.
Adma Biologics Inc stock price yesterday was $13.63.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Adma Biologics Inc's P/E ratio is 17.55.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Adma Biologics Inc P/B ratio is 6.925.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Adma Biologics Inc 50-day moving average is $10.73.